HER‐2/<i>neu</i> overexpression is rare in hepatocellular carcinoma and not predictive of anti‐HER‐2/<i>neu</i> regulation of cell growth and chemosensitivity
2002 · Cancer · 44 citations
https://doi.org/10.1002/cncr.10180
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
7.2K
Citations
47
h-index
91
i10-index
Hey‐Chi Hsu is an academic researcher. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 47, co-authored 108 publications.
https://doi.org/10.1002/cncr.10180
https://doi.org/10.1186/s12885-022-09288-8
Click to start Chat